nivolumab,ipilimumab
bms
['nivolumab', 'lcsm,(-blcsm)', 'nivo', 'ipilimumab', '/ipi', 'nsclc', 'sclc']
frontline nivolumab/ipilimumab plus chemotherapy maintains efficacy advantage in metastatic nsclc #asco23 #lcsm #oncology 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.